Literature DB >> 7594686

Alpha-actinin accumulation in epithelial cells infected with attaching and effacing gastrointestinal pathogens.

A Ismaili1, D J Philpott, M T Dytoc, R Soni, S Ratnam, P M Sherman.   

Abstract

Fluorescent F-actin staining utilizing phalloidin, a highly toxic mushroom poison, is used as an indirect test to detect attaching and effacing (AE) bacteria. A study was done to determine if accumulation of alpha-actinin in infected tissue culture cells is a consistent feature and whether it corresponds with the AE response. Rearrangement of alpha-actinin was detected using immunofluorescence microscopy by incubation of infected cells with a murine monoclonal anti-alpha-actinin antibody. Foci of alpha-actinin-specific fluorescence corresponding to areas of bacterial adhesion were detected by transmission electron microscopy in HEp-2 and gastric KATO-III cells infected with only those bacterial strains that formed AE lesions. Therefore, this study shows that alpha-actinin accumulation is a consistent, specific manifestation of the AE phenotype and forms the basis for the development of a safe alternative test for detecting AE bacteria.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594686     DOI: 10.1093/infdis/172.5.1393

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

Review 1.  Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.

Authors:  Junkal Garmendia; Gad Frankel; Valérie F Crepin
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

2.  Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements.

Authors:  Philip M Sherman; Kathene C Johnson-Henry; Helen P Yeung; Peter S C Ngo; Jacques Goulet; Thomas A Tompkins
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Inhibition of attaching and effacing lesion formation following enteropathogenic Escherichia coli and Shiga toxin-producing E. coli infection.

Authors:  K Johnson-Henry; J L Wallace; N S Basappa; R Soni; G K Wu; P M Sherman
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

4.  Cytoskeletal rearrangements induced by Helicobacter pylori strains in epithelial cell culture: possible role of the cytotoxin.

Authors:  M Ashorn; F Cantet; K Mayo; F Megraud
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

5.  Recruitment of cytoskeletal and signaling proteins to enteropathogenic and enterohemorrhagic Escherichia coli pedestals.

Authors:  D L Goosney; R DeVinney; B B Finlay
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 6.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  Heterogeneity in phenotypic and genotypic characteristics among strains of Hafnia alvei.

Authors:  A Ismaili; B Bourke; J C de Azavedo; S Ratnam; M A Karmali; P M Sherman
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

8.  Divergent signal transduction responses to infection with attaching and effacing Escherichia coli.

Authors:  A Ismaili; E McWhirter; M Y Handelsman; J L Brunton; P M Sherman
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

9.  Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function.

Authors:  K C Johnson-Henry; K A Donato; G Shen-Tu; M Gordanpour; P M Sherman
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

10.  Epithelia under metabolic stress perceive commensal bacteria as a threat.

Authors:  Aisha Nazli; Ping-Chang Yang; Jennifer Jury; Kathryn Howe; James L Watson; Johan D Söderholm; Philip M Sherman; Mary H Perdue; Derek M McKay
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.